This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Comment

. 2011 Jan;12(1):2-3.

doi: 10.1016/S1470-2045(10)70277-1. Epub 2010 Dec 7.

Rational individualised selection of adjuvant therapy for ductal carcinoma in situ

Henry M Kuerer¹

Affiliations

PMID: 21145285
DOI: 10.1016/S1470-2045(10)70277-1

Comment

Rational individualised selection of adjuvant therapy for ductal carcinoma in situ

Henry M Kuerer. Lancet Oncol. 2011 Jan.

. 2011 Jan;12(1):2-3.

doi: 10.1016/S1470-2045(10)70277-1. Epub 2010 Dec 7.

Author

Henry M Kuerer¹

Affiliation

¹ University of Texas MD Anderson Cancer Center, Houston, TX, USA. hkuerer@mdanderson.org

PMID: 21145285
DOI: 10.1016/S1470-2045(10)70277-1

No abstract available

PubMed Disclaimer

Comment on

Effect of tamoxifen and radiotherapy in women with locally excised ductal carcinoma in situ: long-term results from the UK/ANZ DCIS trial.
Cuzick J, Sestak I, Pinder SE, Ellis IO, Forsyth S, Bundred NJ, Forbes JF, Bishop H, Fentiman IS, George WD. Cuzick J, et al. Lancet Oncol. 2011 Jan;12(1):21-9. doi: 10.1016/S1470-2045(10)70266-7. Epub 2010 Dec 7. Lancet Oncol. 2011. PMID: 21145284 Free PMC article. Clinical Trial.

Publication types

Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions
Actions

Substances

Actions

LinkOut - more resources

Full Text Sources
- ClinicalKey
- Elsevier Science
Medical
- MedlinePlus Health Information